Allon Therapeutics Inc. is a clinical-stage biotechnology company focused on bringing to market innovative central nervous system therapies. Allon’s lead drug davunetide, is proceeding in a fully enrolled pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under an SPA with the FDA. This pivotal trial is based upon statistically significant human efficacy demonstrated in amnestic mild cognitive impairment, cognitive impairment associated with schizophrenia, and positive biomarker data. The Company is listed on the Toronto Stock Exchange under the trading symbol “NPC” (Neuro Protection Company™) and based in Vancouver. For additional information please visit the Company's website: www.allontherapeutics.com.
View Top Employees from Allon Therapeutics| Website | https://www.allontherapeutics.com |
| Ticker | TSX:NPC |
| Revenue | $1.6 million |
| Funding | $10 million |
| Employees | 4 (4 on RocketReach) |
| Founded | 2001 |
| Address | 1168 Hamilton St, Vancouver, British Columbia V6B 2S2, CA |
| Phone | (604) 736-0634 |
| Fax | (604) 736-1616 |
| Technologies |
JavaScript,
HTML,
PHP
+4 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Healthcare, Science and Engineering, Drug Discovery, Drug Manufacturing & Research, Clinical Trials, Health Care, Therapeutics |
| Web Rank | 26 Million |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular Allon Therapeutics employee's phone or email?
Allon Therapeutics Questions
The Allon Therapeutics annual revenue was $1.6 million in 2023.
4 people are employed at Allon Therapeutics.
Allon Therapeutics is based in Vancouver, British Columbia.
The NAICS codes for Allon Therapeutics are [541, 54171, 541714, 5417, 54].
The SIC codes for Allon Therapeutics are [873, 87].
Top Allon Therapeutics Employees
-
5+5+
-
1
Related Companies
